Oligonucleotide and mRNA manufacturing infrastructure
Capacity and supply chain security built for global delivery
Hongene Biotech’s RNA-focused state-of-the-art manufacturing sites provide the capacity, resilience, and quality required to support customers worldwide. Our infrastructure is designed to advance oligonucleotide and mRNA programs seamlessly — from early development through to commercial supply.
Manufacturing
- Shanghai (2012): ISO-certified production of phosphoramidites, GalNAc, NTPs and cap analogs
- Shanghai (2020): Expanded capacity for ISO-certified raw materials
- Shanghai (2021): GMP mRNA CDMO services for DS, LNP formulation and fill-finish
- Shanghai (2024): GMP oligonucleotide CDMO services for DS and DP
- Hungary (2027): European GMP oligonucleotide CDMO services and ISO-certified raw materials
Global distribution
- North America (San Francisco): R&D center, warehouse and client support hub
- EMEA (Hamburg): Regional warehouse ensuring secure European supply
Commercial
- Boston, Hamburg, Tokyo: Regional offices providing local sales, logistics, and customer service
Sales Office / R&D Center / Warehouse
Primary Email:
product.info@hongene.comSecondary Email:
info@hongene.com29520 Kohoutek Way, Union City, CA 94587
Sales Office
Email:
product.info@hongene.comEmail:
info@hongene.comOne Broadway, 14th floor Cambridge, MA 02142
Sales Office / Warehouse
Email:
info-eu@hongene.comEmail:
info@hongene.comGrossmoorbogen 25, 21079 Hamburg
Sales Office
Email:
info@hongene.jp403, Kanda lwamotocho Plaza Building, 2-4-1 Iwamoto-Cho, Chiyoda-Ku, Tokyo
mRNA CDMO Facility
Email:
sales@hongene.com9F, Building 315-1, No.333 Guiping Road, Shanghai, China
Manufacturing Facility (2020)
Email:
sales@hongene.comNo. 88, Chuhua Branch Road, Fengxian District, Shanghai, China, 201417
Manufacturing Facility (2012)
Email:
sales@hongene.comNo.60, Beishagang Road, Minhang District, Shanghai, China, 201100